Status:

COMPLETED

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC)

Lead Sponsor:

The Center for Clinical and Cosmetic Research

Collaborating Sponsors:

Sun Pharmaceutical Industries Limited

Conditions:

Facial Cutaneous Squamous Cell Carcinoma in Situ

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The goal of this clinical trial is to test how safe and effective it is to treat early form of cancer cells found in the upper skin layer of the face, using a light-sensitive cream used in combination...

Detailed Description

In the study, participants will be asked to complete the following: * Provide basic personal information (including date of birth, gender, race and ethnicity) * Provide their medical/ surgical histor...

Eligibility Criteria

Inclusion

  • Must be an adult (18 years of age or older)
  • Voluntary written consent required
  • Must have a recently diagnosed (no more than six months from first study visit) facial isSCC lesion that meets surgery excision size requirements
  • Cannot have other dermatological disease in the isSCC target area
  • Must be willing to follow study instructions and complete study requirements, including not using non-approved lotions and creams on the treatments areas
  • If female, cannot be pregnant before and during the study and agree to use acceptable forms of birth control

Exclusion

  • Sensitive to any of the study treatment ingredients
  • Pregnant or lactating
  • Medical laboratory evidence of other non-isSCC tumor in the target lesion biopsy specimen
  • History of recurrence in the target isSCC lesion
  • Medical laboratory evidence of certain growth patterns in the target lesion biopsy specimen
  • Chronic medical condition that in the Investigators opinion will interfere in the trial or affect participant safety

Key Trial Info

Start Date :

August 8 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 13 2024

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT06159842

Start Date

August 8 2023

End Date

November 13 2024

Last Update

February 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center for Clinical and Cosmetic Research

Aventura, Florida, United States, 33180

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (isSCC) | DecenTrialz